Hims & Hers Acquires Health Bridge Medical for $100% Cash Consideration

Hims & Hers Health has agreed to acquire Health Bridge Medical Limited for 100% cash, funded from its balance sheet. The acquisition is expected to close in H2 2025, with no details provided on the financial terms of the deal. The acquisition is part of Hims & Hers' strategy to expand its portfolio of health and wellness services.

Hims & Hers Health Inc. (NYSE: HIMS), the leading health and wellness platform, has announced its intention to acquire Health Bridge Medical Limited for 100% cash, funded from its balance sheet. The acquisition is expected to close in the second half of 2025, with no details provided on the financial terms of the deal. This strategic move is part of Hims & Hers' ongoing efforts to expand its portfolio of health and wellness services.

The acquisition of Health Bridge Medical Limited is a significant step in Hims & Hers' global expansion strategy. Health Bridge Medical is a well-established provider of telemedicine services, with a strong presence in the European market. The acquisition will enable Hims & Hers to leverage Health Bridge's clinical infrastructure and local market expertise, allowing it to offer personalized care services across key European markets.

According to Andrew Dudum, founder and CEO of Hims & Hers, "The demand for simpler, more personalized healthcare is universal. By acquiring Health Bridge Medical, we can expand our reach and offer our services to millions more people across Europe."

David Meinertz, co-founder and CEO of ZAVA, a leading digital health platform in Europe, welcomed the transaction, highlighting the complementary strengths of the two companies. "By joining forces with Hims & Hers, we can put that standard within reach of millions more people across Europe," he said.

The integration of Health Bridge Medical into Hims & Hers will allow the company to offer care across a wide range of health services, including dermatology, weight loss, sexual health, and mental health. The company plans to share more details about the acquisition and its rollout in the coming months, with expectations that the deal will be accretive by 2026.

The acquisition is part of Hims & Hers' broader vision to deliver a seamless, personalized care experience to millions more people globally. With growing demand for direct-to-consumer personalized health services, this acquisition may mark the start of a new phase for global telemedicine.

References:

[1] https://www.investing.com/news/stock-market-news/hims--hers-bets-on-europe-with-zava-deal-shares-climb-4077956
[2] https://investors.hims.com/news/news-details/2025/Hims--Hers-Announces-Plans-to-Acquire-ZAVA-Accelerating-Major-European-Growth-Across-the-UK-Germany-France-and-Ireland/default.aspx